These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2572713)

  • 1. Depressed natural killer (NK) function in blood and marrow is related to the decrease in CD 11+ cells in acute leukemia.
    Morikawa K; Nakano A; Oseko F; Morikawa S
    Jpn J Med; 1989; 28(4):485-91. PubMed ID: 2572713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural killer (NK) cell activity in patients with various malignancy against a variety of target cell lines: re-evaluation of clinical significance of natural killer cell activity.
    Morikawa K; Nakano A; Oseko F; Morikawa S
    Jpn J Med; 1989; 28(4):462-70. PubMed ID: 2810919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of Frequencies, Compositions, and/or Antileukemic Activity of (DC-stimulated) Invariant NKT, NK and CIK Cells on the Outcome of Patients With AML, ALL and CLL.
    Boeck CL; Amberger DC; Doraneh-Gard F; Sutanto W; Guenther T; Schmohl J; Schuster F; Salih H; Babor F; Borkhardt A; Schmetzer H
    J Immunother; 2017; 40(6):224-248. PubMed ID: 28557814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer cells adhere to bone marrow fibroblasts and inhibit adhesion of acute myeloid leukemia cells.
    Bendall LJ; Kortlepel K; Bradstock KF; Gottlieb DJ
    Leukemia; 1995 Jun; 9(6):999-1005. PubMed ID: 7596192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strong natural killer (NK) cell activity in bone marrow of myeloma patients: accelerated maturation of bone marrow NK cells and their interaction with other bone marrow cells.
    Uchida A; Yagita M; Sugiyama H; Hoshino T; Moore M
    Int J Cancer; 1984 Sep; 34(3):375-81. PubMed ID: 6592156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased natural killer cell activity and numbers of Leu-7 and Leu-11b (CD 16)-positive cells in bone marrow of children in remission from acute lymphoblastic leukaemia.
    Sørskaar D; Førre O; Lie SO
    Scand J Immunol; 1989 Jan; 29(1):65-72. PubMed ID: 2466327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High cytotoxic cell activity in the marrow from patients with aplastic anemia.
    Morikawa K; Nakano A; Oseko F; Morikawa S
    Jpn J Med; 1989; 28(5):585-92. PubMed ID: 2585885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered natural killer cell activity in childhood acute non-lymphoid leukaemia. Augmented natural killer cell activity and cells expressing the Leu 7 and Leu 11b (CD 16) markers in the bone marrow of children in remission.
    Sørskaar D; Førre O; Tjønneland S; Lie SO
    Scand J Immunol; 1988 Jul; 28(1):11-7. PubMed ID: 3261034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased circulating large granular lymphocytes associated with depressed natural killer cell activity in renal transplant recipients.
    Ramsey KM; Djeu JY; Rook AH
    Transplantation; 1984 Oct; 38(4):351-6. PubMed ID: 6388061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective NK Cells in Acute Myeloid Leukemia Patients at Diagnosis Are Associated with Blast Transcriptional Signatures of Immune Evasion.
    Khaznadar Z; Boissel N; Agaugué S; Henry G; Cheok M; Vignon M; Geromin D; Cayuela JM; Castaigne S; Pautas C; Raffoux E; Lachuer J; Sigaux F; Preudhomme C; Dombret H; Dulphy N; Toubert A
    J Immunol; 2015 Sep; 195(6):2580-90. PubMed ID: 26246143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer activity of pediatric patients with acute lymphoblastic leukemia in remission.
    Inada M; Okawa H; Suzuki M; Yata J
    Jpn J Clin Oncol; 1984 Sep; 14(3):335-45. PubMed ID: 6592376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute myeloid leukemia impairs natural killer cells through the formation of a deficient cytotoxic immunological synapse.
    Khaznadar Z; Henry G; Setterblad N; Agaugue S; Raffoux E; Boissel N; Dombret H; Toubert A; Dulphy N
    Eur J Immunol; 2014 Oct; 44(10):3068-80. PubMed ID: 25041786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human natural killer cell development from bone marrow progenitors: analysis of phenotype, cytotoxicity and growth.
    Lotzová E; Savary CA
    Nat Immun; 1993; 12(4-5):209-17. PubMed ID: 8257827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Siglec-7 is an indicator of natural killer cell function in acute myeloid leukemia.
    Yang L; Feng Y; Wang S; Jiang S; Tao L; Li J; Wang X
    Int Immunopharmacol; 2021 Oct; 99():107965. PubMed ID: 34273636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer cells in acute myeloid leukemia patients: from phenotype to transcriptomic analysis.
    Venton G; Labiad Y; Colle J; Fino A; Afridi S; Torres M; Monteuil S; Loriod B; Fernandez-Nunez N; Farnault L; Suchon P; Mattei JC; Rihet P; Bergon A; Nguyen C; Baier C; Costello R
    Immunol Res; 2016 Dec; 64(5-6):1225-1236. PubMed ID: 27481509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural killer cells in chronic leukemia. Function and markers.
    Sørskaar D; Førre O; Stavem P
    Int Arch Allergy Appl Immunol; 1988; 87(2):159-64. PubMed ID: 2973442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of cell-mediated cytotoxicity at the single-cell level. VII. Trigger of the lethal hit event is distinct for NK/K and LDCC effector cells as measured in the two-target conjugate assay.
    Bradley TP; Bonavida B
    Cell Immunol; 1984 Jan; 83(1):199-207. PubMed ID: 6420079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural Killer Cell Subpopulations and Inhibitory Receptor Dynamics in Myelodysplastic Syndromes and Acute Myeloid Leukemia.
    Cianga VA; Campos Catafal L; Cianga P; Pavel Tanasa M; Cherry M; Collet P; Tavernier E; Guyotat D; Rusu C; Aanei CM
    Front Immunol; 2021; 12():665541. PubMed ID: 33986753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysis of fresh leukemic blasts by interferon-activated human natural killer cells.
    Pattengale PK; Sundstrom C; Yu AL; Levine A
    Nat Immun Cell Growth Regul; 1983-1984; 3(4):165-80. PubMed ID: 6597341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor activator for NF-κB ligand in acute myeloid leukemia: expression, function, and modulation of NK cell immunosurveillance.
    Schmiedel BJ; Nuebling T; Steinbacher J; Malinovska A; Wende CM; Azuma M; Schneider P; Grosse-Hovest L; Salih HR
    J Immunol; 2013 Jan; 190(2):821-31. PubMed ID: 23241893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.